Pharmalot (Free subscription) | 08/10/2008
The drugmaker is trying to bolster its image after two more bicyclists tested positive for using its Mircera anemia medication, which some athletes apparently use to increase their stamina. Three stage winners in the Tour de France - Stefan Schumacher of Germany and Italy’s Riccardo Ricco and Leonardo Piepoli - have been caught cheating with the [...]
University of Florida News (Free subscription) | 08/10/2008
As people get older, they worry about anemia and whether they’re getting enough iron in their diets. But a University of Florida study shows that over time iron accumulates inside cells.
University of Florida News (Free subscription) | 08/10/2008
As people get older, they worry about anemia and whether they’re getting enough iron in their diets. But a University of Florida study shows that over time iron accumulates inside cells.
Indy Star (Free subscription) | 07/10/2008
Nicole Law has suffered her whole life from a sometimes-painful genetic disease. But confronting sickle cell anemia has taught her that it takes determination to reach a goal, she says.
DTS (Free subscription) | 07/10/2008
What foods are best suited to overcome the anemia caused by iron deficiency in the body? As for meat, red and liver; when it comes to fish, sardines, anchovies, dried cod, clams and mussels. Sausages, ham and loin crude. In the choice of vegetables and legumes, it should be decided by the spinach, the thistle, the beans, lentils and chickpeas. Also dried fruits (hazelnuts, walnuts, almonds, raisins...
Contract Pharma Breaking News (Free subscription) | 03/10/2008
A federal court granted Amgen a permanent injunction prohibiting Roche Holding AG from selling its Mircera anemia treatment in the U.S., as well as upheld a jury verdict regarding certain patent-infringement claims. Mircera is currently available in Europe and the FDA has approved the drug, but the legal dispute prevented its sale. The drug, if released in the U.S., would compete directly with Amgen's...
Pharmalot (Free subscription) | 03/10/2008
A federal judge in Boston ruled the drugmaker infringed on Amgen’s patents with its Mircera anemia med, essentially upholding a preliminary decision issued in February. The order by US District Court Judge William Young deals a big setback to Roche, which already cut costs after its plans to market Mircera flopped and further underscores its [...]
Pharmalot (Free subscription) | 02/10/2008
The first shoe to drop after last week’s Pfizer board meeting involves cutting back several research areas, including heart disease, anemia, osteoarthritis and obesity, according to a September 25 memo from research chief Martin Mackay to employees. Yes, most of you know this by now, because the news trickled out earlier this week. But we [...]
Health - The Post Chronicle (Free subscription) | 29/09/2008
The federal agency said the German study is investigating whether the anti-anemia drug epoetin alfa,...
Times of the Internet (Free subscription) | 29/09/2008
WASHINGTON, Sept. 29 (UPI) -- The U.S. Food and Drug Administration issued an advisory about preliminary results of a German study involving the drug known as Procrit, Eprex or Epogen. The federal agency said the German study is investigating whether the anti-anemia drug epoetin alfa, marketed as Eprex in Germany, can improve the neurological functioning of stroke victims. The FDA said three months...
Red Orbit (Free subscription) | 29/09/2008
Fetal anemia is a dangerous pregnancy complication that can wreak havoc on unborn babies. Now, there is an easier way to spot the condition without resorting to amniocentesis.
PharmaGossip (Free subscription) | 29/09/2008
Preliminary results from a German study suggest that stroke patients' use of anti-anemia drugs such as Aranesp, Procrit and Epogen might end up boosting their risk for death, the U.S. Food and Drug Administration (FDA) warned on Friday. The goal of the study was to see if high doses of the anti-anemia drug epoetin alfa could improve the ability of stroke patients to take care of themselves after recovering...
HealthLawProf Blog (Free subscription) | 27/09/2008
The New York Times reports that federal health officials, on September 26, said that they were reviewing a higher rate of deaths among patients treated with a Johnson & Johnson anemia drug in a German study of stroke patients. The...
Reuters UK (Free subscription) | 26/09/2008
WASHINGTON (Reuters) - U.S. health officials said on Friday they were reviewing a higher rate of deaths among patients treated with a Johnson & Johnson anemia drug in a study of stroke patients.
Reuters (Free subscription) | 26/09/2008
WASHINGTON (Reuters) - More patients died after treatment with a Johnson & Johnson anemia drug in a study testing whether the medicine could improve brain function in stroke patients, U.S. regulators said on Friday.
